Xeris Biopharma Holdings, Inc. (XERS)

NASDAQ: XERS · IEX Real-Time Price · USD

1.780

+0.040 (2.30%)

At close: Apr 22, 2024, 4:00 PM

1.770

-0.010 (-0.56%)

After-hours: Apr 22, 2024, 7:30 PM EDT

Xeris Biopharma Holdings Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Revenue	163.91	110.25	49.59	20.44	2.72	2.42	1.56	1.08
Revenue Growth (YoY)	48.68%	122.32%	142.67%	650.73%	12.34%	55.72%	44.74%	-
Cost of Revenue	28.65	22.63	13.32	9.33	1.6	0	0	0.01
Gross Profit	135.27	87.61	36.27	11.11	1.12	2.42	1.55	1.07
Selling, General & Admin	146.1	137.75	125.72	73.73	63.06	21.11	8.02	4.06
Research & Development	22.34	20.97	25.16	20.92	60.44	40.65	20.17	10.24
Other Operating Expenses	10.84	10.84	0.55	0	0	0	0	0
Operating Expenses	179.28	169.55	151.43	94.65	123.5	61.77	28.18	14.3
Operating Income	-44.01	-81.94	-115.16	-83.55	-122.38	-59.34	-26.63	-13.23
Interest Expense / Income	26.61	14.1	7.18	10.66	7.16	2.55	0	0
Other Expense / Income	-7.12	0.04	0.39	-2.96	-3.51	-1.81	-0.08	-0.02
Pretax Income	-63.5	-96.08	-122.73	-91.25	-126.04	-60.08	-26.55	-13.21
Income Tax	-1.25	-1.42	0	-0.11	-0.46	0	0	0
Net Income	-62.26	-94.66	-122.73	-91.14	-125.58	-60.08	-26.55	-13.21
Shares Outstanding (Basic)	138	136	79	43	26	12	2	2
Shares Outstanding (Diluted)	138	136	79	43	26	12	2	2
Shares Change	1.51%	71.62%	85.32%	63.32%	116.75%	493.92%	10.09%	-
EPS (Basic)	-0.45	-0.70	-1.55	-2.14	-4.81	-4.99	-13.09	-7.17
EPS (Diluted)	-0.45	-0.70	-1.55	-2.14	-4.81	-4.99	-13.09	-7.17
Free Cash Flow	-49.29	-103.42	-96.62	-80.94	-105.45	-57.79	-25.36	-16.12
Free Cash Flow Per Share	-0.36	-0.76	-1.22	-1.90	-4.04	-4.80	-12.51	-8.75
Gross Margin	82.52%	79.47%	73.14%	54.35%	41.11%	100.00%	99.74%	99.26%
Operating Margin	-26.85%	-74.32%	-232.22%	-408.84%	-4495.96%	-2449.20%	-1711.38%	-1230.79%
Profit Margin	-37.98%	-85.86%	-247.48%	-446.00%	-4613.52%	-2479.57%	-1706.56%	-1228.74%
Free Cash Flow Margin	-30.07%	-93.80%	-194.84%	-396.06%	-3874.10%	-2385.02%	-1630.01%	-1499.72%
EBITDA	-23.74	-69.31	-113.67	-79.12	-117.8	-57.22	-26.33	-13.09
EBITDA Margin	-14.48%	-62.87%	-229.21%	-387.19%	-4327.59%	-2361.33%	-1691.97%	-1217.77%
Depreciation & Amortization	13.16	12.67	1.88	1.47	1.08	0.32	0.23	0.12
EBIT	-36.9	-81.98	-115.55	-80.59	-118.88	-57.54	-26.55	-13.21
EBIT Margin	-22.51%	-74.36%	-233.00%	-394.37%	-4367.19%	-2374.54%	-1706.43%	-1228.56%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).